Kepler Capital analyst Arnaud Girod maintained a Buy rating on Tecan Group AG (SIX:TECN) on Wednesday, setting a price target of CHF640, which is approximately 27.85% above the present share price of $541.65.
Girod expects Tecan Group AG to post earnings per share (EPS) of $0.00 for the fourth quarter of 2021.
The current consensus among 3 TipRanks analysts is for a Strong Buy rating of shares in Tecan Group AG, with an average price target of $663.63.
The analysts price targets range from a high of $692.48 to a low of $643.79.
In its latest earnings report, released on 06/30/2021, the company reported a quarterly revenue of $0 and a net profit of $0. The company's market cap is $6.91 billion.
According to TipRanks.com, Kepler Capital analyst Arnaud Girod is currently ranked with 3 stars on a 0-5 stars ranking scale, with an average return of 1.5% and a 52.15% success rate.
Tecan Group AG is a holding company, which engages in the development, production, and distribution of laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics. It operates through the following segments: Life Sciences Business, Partnering Business, and Corporate. The Life Sciences Business segment supplies end users with automated workflow solutions, which includes laboratory instruments, software packages, application know-how, services, consumables, and spare parts. The Partnering Business segment develops and manufactures original equipment manufacturer instruments and components. The company was founded by Heinz Abplanalp, Heini Maurer, Heini Moeckli, and Gallus Blatter on March 18, 1980 and is headquartered in Mannedorf, Switzerland.